0,724  0,003  GABA C receptor rho-3 antagonist
0,534  0,007  Ca2+/calmodulin-dependent protein kinase inhibitor
0,534  0,020  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,521  0,022  Aryl hydrocarbon receptor agonist
0,491  0,008  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,482  0,004  Hedgehog signaling inhibitor
0,471  0,009  Cyclic AMP phosphodiesterase inhibitor
0,436  0,005  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,430  0,012  Antineoplastic (bladder cancer)
0,430  0,012  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,420  0,004  Toll-Like receptor 9 antagonist
0,446  0,037  5 Hydroxytryptamine release stimulant
0,453  0,049  Histamine release inhibitor
0,418  0,014  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,412  0,009  Protein kinase C nu inhibitor
0,424  0,022  Huntington's disease treatment
0,437  0,036  Anxiolytic
0,400  0,003  GABA C receptor rho-2 antagonist
0,377  0,004  Vasculitis treatment
0,420  0,047  MAP kinase kinase 6 inhibitor
0,414  0,045  Aldehyde oxidase inhibitor
0,407  0,049  Antiprotozoal (Plasmodium)
0,358  0,005  Aldehyde oxidase substrate
0,370  0,027  Pyruvate kinase inhibitor
0,408  0,066  Rheumatoid arthritis treatment
0,342  0,004  Protein kinase C mu inhibitor
0,337  0,005  GABA receptor agonist
0,341  0,011  Phosphodiesterase inhibitor
0,345  0,015  Systemic lupus erythematosus treatment
0,329  0,004  Antiprotozoal (Babesia)
0,358  0,034  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,388  0,069  Antineoplastic (myeloid leukemia)
0,354  0,036  Dyrk kinase inhibitor
0,417  0,101  Caspase 9 stimulant
0,383  0,076  Antiprotozoal
0,376  0,071  CYP2C9 substrate
0,308  0,004  Protein kinase C gamma inhibitor
0,353  0,050  CYP1A2 substrate
0,304  0,004  NAT2 substrate
0,331  0,032  Clk dual-specificity kinase inhibitor
0,366  0,075  Antineoplastic (lung cancer)
0,295  0,007  Toll-Like receptor antagonist
0,293  0,005  Protein kinase C zeta inhibitor
0,334  0,051  Hypoxia-inducible factor 1 alpha inhibitor
0,287  0,004  GABA A receptor antagonist
0,328  0,047  FMO3 substrate
0,289  0,012  DNA intercalator
0,356  0,080  Ulceration
0,279  0,005  GABA A receptor agonist
0,279  0,004  GABA receptor antagonist
0,323  0,051  CYP1A2 inhibitor
0,378  0,109  Alzheimer's disease treatment
0,347  0,082  Antileukemic
0,284  0,020  Muscular dystrophy treatment
0,332  0,070  FMO1 substrate
0,341  0,082  Cognition disorders treatment
0,294  0,035  ErbB-1 antagonist
0,292  0,034  CDC-like kinase 4 inhibitor
0,329  0,072  Antineoplastic (colorectal cancer)
0,301  0,047  GST M1-1 substrate
0,290  0,038  Tyrosine 3 hydroxylase inhibitor
0,306  0,055  Antiprotozoal (Trypanosoma)
0,314  0,063  Antineoplastic (small cell lung cancer)
0,284  0,034  Ca2+/calmodulin-dependent kinase IV inhibitor
0,275  0,030  Pneumotoxic
0,284  0,039  MAP-kinase-activated kinase 5 inhibitor
0,314  0,071  Antineoplastic (colon cancer)
0,257  0,019  NADPH oxidase inhibitor
0,278  0,043  MAP kinase kinase 2 inhibitor
0,242  0,007  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,322  0,086  Inflammatory Bowel disease treatment
0,262  0,032  I kappa B kinase epsilon inhibitor
0,234  0,005  Smo receptor antagonist
0,250  0,021  Activin receptor-like kinase 2 inhibitor
0,232  0,005  GABA C receptor rho-1 antagonist
0,267  0,040  CDC-like kinase 2 inhibitor
0,247  0,020  Glycogen synthase kinase-3 beta inhibitor
0,252  0,025  Protein kinase (CK1) inhibitor
0,271  0,046  Death-associated protein kinase 3 inhibitor
0,283  0,063  Radiosensitizer
0,230  0,014  MAP kinase 13 inhibitor
0,240  0,023  Glycogen synthase kinase-3 inhibitor
0,231  0,016  Ferrochelatase inhibitor
0,229  0,015  MAP kinase 12 inhibitor
0,231  0,020  Protein kinase (CK1) delta inhibitor
0,219  0,009  Sphingosine 1-phosphate receptor 2 agonist
0,335  0,129  5 Hydroxytryptamine release inhibitor
0,272  0,069  Flavin-containing monooxygenase substrate
0,293  0,090  Mood disorders treatment
0,284  0,083  Nootropic
0,269  0,069  Antineoplastic (non-small cell lung cancer)
0,229  0,031  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,201  0,004  Benzodiazepine agonist
0,219  0,026  Hexokinase inhibitor
0,264  0,073  DNA damaging
0,217  0,025  Antianemic
0,212  0,022  Cystathionine beta-synthase inhibitor
0,194  0,005  Phosphodiesterase 10A inhibitor
0,194  0,005  Phosphodiesterase X inhibitor
0,338  0,149  Antineoplastic (solid tumors)
0,272  0,083  Antineoplastic (melanoma)
0,236  0,047  MAP kinase kinase 3 inhibitor
0,253  0,065  Potassium channel (Voltage-sensitive) blocker
0,213  0,029  Carcinogenic, group 1
0,249  0,067  DNA synthesis inhibitor
0,198  0,016  MAP3K9 inhibitor
0,215  0,033  Interleukin 6 antagonist
0,196  0,015  MAP kinase kinase 4 inhibitor
0,199  0,020  Aurora-C kinase inhibitor
0,190  0,015  GABA C receptor antagonist
0,206  0,033  CDC-like kinase 1 inhibitor
0,189  0,015  Protein kinase A inhibitor
0,212  0,040  VEGF expression inhibitor
0,181  0,010  Transcription factor STAT6 inhibitor
0,262  0,090  Cardioprotectant
0,205  0,035  Ribosomal protein S6 kinase inhibitor
0,184  0,017  Photosensitizer
0,246  0,079  5 Hydroxytryptamine 1E antagonist
0,195  0,028  Topoisomerase I inhibitor
0,171  0,005  Caspase 7 inhibitor
0,187  0,021  Beta amyloid protein antagonist
0,201  0,035  Cyclin-dependent kinase 8 inhibitor
0,230  0,066  Antiparkinsonian, rigidity relieving
0,220  0,058  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,167  0,006  Protein kinase C eta inhibitor
0,234  0,073  HERG channel blocker
0,211  0,050  Diabetic nephropathy treatment
0,222  0,061  Sedative
0,281  0,121  GST A substrate
0,178  0,019  Activin receptor-like kinase 4 inhibitor
0,276  0,117  Calcium channel activator
0,175  0,016  Multidrug resistance-associated protein 1 inhibitor
0,244  0,087  5 Hydroxytryptamine uptake stimulant
0,169  0,014  Platelet growth factor antagonist
0,182  0,026  Antiprotozoal (Amoeba)
0,257  0,102  CTGF expression inhibitor
0,223  0,069  Anticonvulsant
0,160  0,006  Bromodomain-containing protein 2 inhibitor
0,189  0,036  Topoisomerase II inhibitor
0,189  0,036  Antinephritic
0,157  0,004  Protein kinase C beta inhibitor
0,206  0,053  5 Hydroxytryptamine 3E antagonist
0,173  0,020  Pim-1 kinase inhibitor
0,315  0,164  MAP kinase 1 inhibitor
0,159  0,008  5 Hydroxytryptamine 3 antagonist
0,179  0,030  Antiprotozoal (Trichomonas)
0,173  0,024  Polo-like kinase-4 inhibitor
0,240  0,091  Gastrin inhibitor
0,152  0,005  5 Hydroxytryptamine 3 agonist
0,217  0,072  Cytotoxic
0,153  0,010  Protein kinase C alpha inhibitor
0,156  0,016  Pim-3 kinase inhibitor
0,182  0,044  Genotoxic
0,242  0,106  Antihypoxic
0,203  0,066  TRKC antagonist
0,138  0,003  MAP kinase 7 inhibitor
0,251  0,117  Antineoplastic (brain cancer)
0,154  0,021  Myasthenia Gravis treatment
0,152  0,020  Phosphodiesterase 7B inhibitor
0,152  0,020  Protein kinase C delta inhibitor
0,196  0,065  LIM domain kinase 1 inhibitor
0,170  0,039  Movement disorders treatment
0,216  0,085  Antiviral (West Nile virus)
0,303  0,173  Autoimmune disorders treatment
0,146  0,017  MAP kinase 10 inhibitor
0,232  0,104  UGT2B4 substrate
0,163  0,035  Aurora-A kinase inhibitor
0,202  0,075  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,178  0,050  Cyclin-dependent kinase 3 inhibitor
0,158  0,031  Heat shock protein 70 antagonist
0,162  0,035  Pregnane X receptor agonist
0,176  0,049  CNS active muscle relaxant
0,176  0,049  RET inhibitor
0,270  0,144  Antipruritic, allergic
0,160  0,035  Platelet activating factor beta antagonist
0,249  0,124  Angiogenesis inhibitor
0,197  0,073  Histone acetyltransferase inhibitor
0,140  0,017  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,227  0,104  Antipsychotic
0,153  0,031  Contraceptive female
0,273  0,151  CYP2C19 inhibitor
0,179  0,057  Antiviral (Hepatitis C)
0,130  0,008  Bromodomain-containing protein 4 inhibitor
0,143  0,022  CDC-like kinase 3 inhibitor
0,151  0,031  Check point kinase 2 inhibitor
0,211  0,092  Antiamyloidogenic
0,193  0,074  Antiviral (Ebola)
0,184  0,065  Antineoplastic (gastric cancer)
0,152  0,034  5 Hydroxytryptamine 3A agonist
0,152  0,034  SULT1A1 substrate
0,149  0,031  Fibroblast growth factor 1 antagonist
0,167  0,050  Cytokine production inhibitor
0,162  0,045  MAP kinase kinase inhibitor
0,142  0,026  Arylamine N-Acetyltransferase substrate
0,119  0,004  Benzodiazepine inverse agonist
0,149  0,034  Cyclin-dependent kinase 9 inhibitor
0,119  0,004  Antiviral (Bovine viral diarrhea virus)
0,119  0,005  Antidote, organophosphates
0,157  0,044  Aldehyde dehydrogenase inhibitor
0,213  0,101  Antineoplastic (renal cancer)
0,133  0,022  Phosphodiesterase I inhibitor
0,149  0,038  MAP kinase 9 inhibitor
0,129  0,018  Phosphodiesterase 6D inhibitor
0,247  0,138  Vasodilator, coronary
0,154  0,045  Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor
0,154  0,045  Abl kinase inhibitor
0,140  0,031  Antineoplastic alkaloid
0,172  0,064  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,182  0,074  Interleukin-1 receptor-associated protein kinase 1 inhibitor
0,200  0,093  Potassium channel blocker
0,145  0,038  Interleukin 8 antagonist
0,165  0,058  Antiparkinsonian, tremor relieving
0,260  0,153  CYP2C9 inhibitor
0,164  0,057  Glycogen synthase kinase-3 alpha inhibitor
0,170  0,064  Cystic fibrosis treatment
0,181  0,076  Tyrosine kinase inhibitor
0,235  0,131  CYP3A4 inhibitor
0,120  0,015  Protein kinase B beta inhibitor
0,110  0,006  Glutamate (mGluR7) antagonist
0,132  0,029  Carcinogenic, group 2A
0,202  0,100  Antineoplastic (cervical cancer)
0,110  0,009  Fatty acid synthase inhibitor
0,200  0,099  RNA-directed DNA polymerase inhibitor
0,216  0,116  Transcription factor STAT inhibitor
0,128  0,029  Interleukin 1 beta converting enzyme inhibitor
0,178  0,079  Antiviral (Hepatitis)
0,103  0,005  5 Hydroxytryptamine 3B antagonist
0,123  0,025  I kappa B kinase inhibitor
0,239  0,141  CYP3A4 substrate
0,222  0,124  Antidepressant
0,158  0,060  Antineoplastic (squamous cell carcinoma)
0,122  0,025  MAP kinase 11 inhibitor
0,103  0,006  Antihemophilic
0,182  0,086  Focal adhesion kinase 2 inhibitor
0,113  0,017  I kappa B kinase 1 inhibitor
0,108  0,013  5 Hydroxytryptamine 3A antagonist
0,117  0,024  Glutamate release inhibitor
0,138  0,045  Carcinogenic, group 2B
0,195  0,104  Antiprotozoal (Leishmania)
0,184  0,093  Neurotrophic factor enhancer
0,165  0,074  Protein kinase (CK1) gamma 3 inhibitor
0,123  0,033  MAP kinase kinase 1 inhibitor
0,190  0,100  VCAM1 expression inhibitor
0,208  0,118  UGT1A9 substrate
0,127  0,038  Obsessive-compulsive disorder treatment
0,205  0,118  Antineoplastic (sarcoma)
0,139  0,051  Aurora-B kinase inhibitor
0,107  0,022  Sphingosine 1-phosphate receptor 4 agonist
0,134  0,049  5 Hydroxytryptamine 2B antagonist
0,157  0,072  Urolithiasis treatment
0,097  0,011  Cyclin-dependent kinase 6 inhibitor
0,112  0,026  5 Hydroxytryptamine 1F antagonist
0,149  0,063  Sphingosine 1-phosphate receptor 5 antagonist
0,109  0,024  mTOR complex 2 inhibitor
0,134  0,049  DNA repair enzyme inhibitor
0,104  0,020  Transforming growth factor beta 3 antagonist
0,105  0,021  Polo-like kinase-2 inhibitor
0,175  0,092  CYP2B6 inhibitor
0,112  0,030  Rho-associated kinase inhibitor
0,104  0,022  Adenosine A1 receptor antagonist
0,110  0,029  p38 MAP kinase inhibitor
0,107  0,026  Granulocyte macrophage colony stimulating factor agonist
0,212  0,132  CYP2D6 substrate
0,143  0,063  Ca2+-transporting ATPase inhibitor
0,106  0,027  Protein kinase B alpha inhibitor
0,098  0,020  MAP kinase kinase 10 inhibitor
0,148  0,070  Antineoplastic (carcinoma)
0,158  0,081  UGT1A4 substrate
0,090  0,013  Toll-Like receptor 8 antagonist
0,092  0,015  Protein kinase C epsilon inhibitor
0,136  0,059  Antismoking
0,089  0,013  Phosphodiesterase 1A inhibitor
0,186  0,110  Antineoplastic (lymphocytic leukemia)
0,099  0,024  CDC7 inhibitor
0,184  0,109  UGT1A6 substrate
0,146  0,072  Protein kinase (CK1) gamma 1 inhibitor
0,083  0,009  Potassium channel small-conductance Ca-activated blocker
0,090  0,016  I kappa B kinase 2 inhibitor
0,140  0,067  Cyclin-dependent kinase 7 inhibitor
0,184  0,110  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,109  0,036  Antidote, mercury
0,096  0,024  Toll-Like receptor 7 antagonist
0,157  0,085  Neurotensin receptor agonist
0,085  0,013  Corticotropin releasing factor 2 receptor antagonist
0,126  0,054  Cyclin-dependent kinase 5 inhibitor
0,123  0,053  Excitatory amino acid transporter EAAC1 inhibitor
0,075  0,005  Benzodiazepine antagonist
0,201  0,131  CYP2C19 substrate
0,087  0,018  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,103  0,034  CYP2A6 inhibitor
0,089  0,021  TRPA1 antagonist
0,106  0,039  Leucine-rich repeat kinase 2 inhibitor
0,132  0,066  Cyclin-dependent kinase inhibitor
0,085  0,019  Pim-2 kinase inhibitor
0,103  0,037  MAP-kinase-activated kinase inhibitor
0,092  0,026  Phosphodiesterase VI inhibitor
0,082  0,017  mTOR inhibitor
0,094  0,029  Adenosine A3 receptor antagonist
0,070  0,007  Potassium channel small-conductance Ca-activated activator
0,155  0,092  ATPase inhibitor
0,143  0,080  MAP kinase 3 inhibitor
0,097  0,035  Telomerase inhibitor
0,165  0,104  Abortion inducer
0,089  0,027  MAP kinase kinase 7 inhibitor
0,182  0,120  Cytostatic
0,073  0,011  Histamine H4 receptor antagonist
0,079  0,018  Phosphodiesterase II inhibitor
0,110  0,049  Creatine kinase inhibitor
0,068  0,008  Alpha 1d adrenoreceptor agonist
0,109  0,051  Antifungal (Aspergillus)
0,100  0,041  Bcr-Abl kinase inhibitor
0,078  0,019  Potassium channel (Ca-activated) blocker
0,102  0,044  Histamine N-methyltransferase inhibitor
0,132  0,075  Death-associated protein kinase 1 inhibitor
0,095  0,037  Glycine receptor antagonist
0,120  0,063  Menstruation disorders treatment
0,101  0,044  Polo-like kinase-1 inhibitor
0,091  0,034  MAP-kinase-activated kinase 2 inhibitor
0,094  0,037  Fibroblast growth factor 3 antagonist
0,128  0,071  Acetylcholinesterase inhibitor
0,110  0,054  Butyrylcholinesterase inhibitor
0,152  0,096  UGT2B10 substrate
0,126  0,070  c-Src kinase inhibitor
0,081  0,025  Phosphatidylinositol 3-kinase delta inhibitor
0,080  0,026  Protein kinase C iota inhibitor
0,171  0,117  Antineoplastic (glioma)
0,086  0,032  Adenosine A2 receptor antagonist
0,161  0,107  Psychostimulant
0,134  0,080  Growth factor antagonist
0,077  0,024  Phosphodiesterase 1B inhibitor
0,112  0,059  Cyclin-dependent kinase 1 inhibitor
0,076  0,023  Phosphatidylinositol 3-kinase alpha inhibitor
0,071  0,018  Phosphodiesterase 2A inhibitor
0,080  0,028  Phosphatidylinositol kinase inhibitor
0,061  0,009  RNA-directed RNA polymerase inhibitor
0,090  0,038  Janus tyrosine kinase 3 inhibitor
0,186  0,134  Superoxide dismutase inhibitor
0,141  0,090  Neuropathy treatment
0,079  0,028  Aryl hydrocarbon receptor antagonist
0,074  0,024  Cyclin D1 inhibitor
0,085  0,035  Cyclin B3 inhibitor
0,076  0,026  Glutamate (mGluR1) antagonist
0,061  0,011  GABA B receptor antagonist
0,082  0,033  MAP kinase kinase 8 inhibitor
0,082  0,033  Fibroblast growth factor 2 antagonist
0,112  0,064  Endometrios treatment
0,082  0,033  5 Hydroxytryptamine 1B antagonist
0,157  0,110  Antirickettsial
0,070  0,024  Melanin-concentrating hormone receptor 1 antagonist
0,162  0,116  Growth factor agonist
0,159  0,113  Antimitotic
0,073  0,027  5 Hydroxytryptamine 6 antagonist
0,178  0,132  Antineoplastic (liver cancer)
0,081  0,035  Phosphodiesterase III inhibitor
0,163  0,117  EphB2 antagonist
0,113  0,068  Platelet activating factor antagonist
0,083  0,037  Phosphodiesterase 5A inhibitor
0,090  0,045  D-Ala-D-Ala ligase inhibitor
0,150  0,105  Death-associated protein kinase 2 inhibitor
0,083  0,038  Phosphodiesterase V inhibitor
0,090  0,045  Acetylcholine nicotinic agonist
0,132  0,087  Skeletal muscle relaxant
0,110  0,066  Acetylcholine release stimulant
0,069  0,025  Phosphatidylinositol 3-kinase gamma inhibitor
0,123  0,079  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,070  0,027  Phosphodiesterase 4C inhibitor
0,106  0,063  GST T1-1 substrate
0,076  0,033  Adenosine A2a receptor antagonist
0,049  0,006  Protein kinase C beta II inhibitor
0,136  0,094  Src kinase inhibitor
0,134  0,092  Cholinergic
0,125  0,084  Sphingosine 1-phosphate receptor 2 antagonist
0,071  0,030  5 Hydroxytryptamine 5A antagonist
0,054  0,013  Angiotensin AT1 receptor antagonist
0,174  0,133  Heart failure treatment
0,057  0,017  Cytokine production stimulant
0,098  0,058  Prolactin inhibitor
0,071  0,031  Cyclin B1 inhibitor
0,080  0,041  Syk tyrosine kinase inhibitor
0,113  0,073  Shock treatment
0,065  0,026  Cyclin B2 inhibitor
0,083  0,044  Rho-associated kinase I inhibitor
0,069  0,031  Transcription factor RelA inhibitor
0,139  0,101  Uterine stimulant
0,049  0,010  HCV NS5B polymerase inhibitor
0,151  0,113  Antimigraine
0,081  0,043  NAT1 substrate
0,110  0,073  Mental retardation treatment
0,103  0,067  Mediator release inhibitor
0,096  0,060  Posttraumatic stress disorder treatment
0,060  0,024  Adenosine A2b receptor antagonist
0,109  0,074  Protein kinase (CK1) gamma 2 inhibitor
0,081  0,046  Acetylcholine M4 receptor antagonist
0,072  0,037  5 Hydroxytryptamine 1D antagonist
0,051  0,017  Nerve growth factor antagonist
0,205  0,170  Vasodilator, peripheral
0,145  0,112  Amyloid beta aggregation inhibitor
0,077  0,043  S-adenosyl-L-methionine decarboxylase inhibitor
0,042  0,009  Adenosine uptake inhibitor
0,064  0,031  5 Hydroxytryptamine 5 antagonist
0,094  0,061  HIV-1 integrase (Overall Integration) inhibitor
0,090  0,057  Gastroesophageal reflux disease treatment
0,118  0,086  Sodium channel (voltage-gated) blocker
0,083  0,051  Topoisomerase II alpha inhibitor
0,132  0,100  UGT1A3 substrate
0,080  0,049  Focal adhesion kinase 1 inhibitor
0,058  0,027  Transforming growth factor beta 1 antagonist
0,070  0,039  MDM2 inhibitor
0,142  0,112  DNA methyltransferase I inhibitor
0,096  0,066  Insulin receptor antagonist
0,060  0,031  MAP kinase kinase 9 inhibitor
0,034  0,005  Imidazoline I1 receptor antagonist
0,039  0,010  Protein kinase C beta I inhibitor
0,140  0,112  Hearing loss treatment
0,083  0,055  ALK inhibitor
0,088  0,060  NADH dehydrogenase inhibitor
0,134  0,106  Heat shock protein 90 alpha antagonist
0,069  0,042  Cyclin-dependent kinase 4 inhibitor
0,079  0,051  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,099  0,072  5 Hydroxytryptamine 2 antagonist
0,133  0,106  Muscle relaxant
0,118  0,092  Protein kinase (CK1) gamma inhibitor
0,132  0,106  Polo-like kinase-3 inhibitor
0,039  0,013  ATR kinase inhibitor
0,126  0,100  Acetylcholine M1 receptor antagonist
0,059  0,033  Cyclin B inhibitor
0,040  0,015  Angiotensin II receptor antagonist
0,079  0,054  Glutamate receptor agonist
0,056  0,031  Histamine agonist
0,044  0,019  MAP3K5 inhibitor
0,098  0,074  Beta glucuronidase inhibitor
0,120  0,096  Nav1.6 sodium channel blocker
0,043  0,020  Protein kinase (CK1) epsilon inhibitor
0,080  0,056  Xanthine oxidase substrate
0,053  0,029  AMPA receptor antagonist
0,045  0,022  Acid-sensing ion channel blocker
0,090  0,067  CDK2/cyclin A inhibitor
0,082  0,059  5 Hydroxytryptamine 2C antagonist
0,038  0,015  Protein kinase (CK2) beta inhibitor
0,099  0,076  Alpha 2b adrenoreceptor antagonist
0,175  0,154  Respiratory analeptic
0,068  0,046  Acetylcholine M5 receptor agonist
0,061  0,039  Potassium channel intermediate-conductance Ca-activated blocker
0,114  0,093  Antihelmintic (Trematoda)
0,057  0,036  5 Hydroxytryptamine 7 agonist
0,046  0,024  DNA-dependent protein kinase inhibitor
0,064  0,043  Cyclin A2 inhibitor
0,025  0,005  Vesicular glutamate transport inhibitor
0,067  0,047  Phosphodiesterase 4B inhibitor
0,145  0,125  Antineoplastic (glioblastoma multiforme)
0,056  0,036  Immunoglobulin Fc receptor antagonist
0,093  0,074  Gastric antisecretory
0,125  0,106  Heat shock protein 90 antagonist
0,037  0,018  Benzodiazepine receptor peripheral-type antagonist
0,069  0,050  Transforming growth factor antagonist
0,176  0,158  Amyotrophic lateral sclerosis treatment
0,103  0,085  TRKA antagonist
0,119  0,101  Peroxidase inhibitor
0,045  0,027  Histamine H1 receptor agonist
0,032  0,014  5 Hydroxytryptamine 6 agonist
0,146  0,128  Phobic disorders treatment
0,071  0,054  MAP kinase 14 inhibitor
0,047  0,029  Phosphodiesterase 6C inhibitor
0,058  0,040  Fibroblast growth factor 4 antagonist
0,119  0,102  Mannose-6-phosphate isomerase inhibitor
0,098  0,081  Tyrosine-protein kinase receptor FLT3 inhibitor
0,050  0,033  Bromodomain-containing protein 3 inhibitor
0,092  0,074  Tourette's syndrome treatment
0,194  0,177  Antihypertensive
0,090  0,073  Protein kinase (CK2) inhibitor
0,096  0,080  Protein kinase (CK2) alpha inhibitor
0,184  0,168  Prostaglandin dehydrogenase inhibitor
0,111  0,095  Tyrosine-protein kinase receptor antagonist
0,045  0,030  Dihydroorotase inhibitor
0,043  0,028  Guanylate cyclase inhibitor
0,046  0,031  Purinergic P2X4 antagonist
0,035  0,021  CDK6/cyclin D3 inhibitor
0,080  0,066  Acetylcholine agonist
0,073  0,059  Nicotinic alpha4beta2 receptor antagonist
0,051  0,037  Aconitate hydratase inhibitor
0,212  0,200  15-Lipoxygenase inhibitor
0,054  0,041  Nicotinic neuronal receptor agonist
0,064  0,052  Nav1.7 sodium channel blocker
0,077  0,065  AXL receptor tyrosine kinase inhibitor
0,089  0,077  MAP kinase kinase kinase inhibitor
0,068  0,057  Phosphodiesterase 4D inhibitor
0,071  0,060  Glutamate (mGluR) antagonist
0,074  0,063  Histamine H1 receptor antagonist
0,048  0,037  Topoisomerase II beta inhibitor
0,030  0,019  Cyclin E2 inhibitor
0,034  0,024  Retinoid X alpha receptor antagonist
0,165  0,155  Antineoplastic (ovarian cancer)
0,037  0,027  Retinoid X receptor antagonist
0,094  0,084  5 Hydroxytryptamine antagonist
0,074  0,064  TIE-2 antagonist
0,058  0,048  CDK1/cyclin B inhibitor
0,082  0,073  Potassium channel (Ca-activated) activator
0,014  0,005  Imidazoline I2 receptor antagonist
0,051  0,042  Nicotinic alpha7 receptor agonist
0,054  0,046  Protein kinase C theta inhibitor
0,063  0,054  Phenylalanine 4-hydroxylase inhibitor
0,037  0,029  Glutamate (mGluR group II) antagonist
0,091  0,083  Granulocyte macrophage colony stimulating factor antagonist
0,029  0,022  Glutamate (mGluR2) antagonist
0,111  0,104  Interleukin 1 antagonist
0,073  0,066  TIE antagonist
0,037  0,030  Cyclin D3 inhibitor
0,115  0,108  Mutagenic
0,041  0,035  Phosphodiesterase 3B inhibitor
0,087  0,081  Urease inhibitor
0,136  0,130  DNA methylase inhibitor
0,112  0,106  UGT2B15 substrate
0,098  0,093  MAO inhibitor
0,099  0,094  Autism spectrum disorders treatment
0,090  0,086  Adenylate kinase inhibitor
0,219  0,215  Antiparkinsonian
0,065  0,061  SULT2A1 substrate
0,063  0,059  Prostaglandin-E synthase inhibitor
0,076  0,073  CDK/cyclin complex inhibitor
0,084  0,082  MAP kinase 8 inhibitor
0,096  0,093  Nav1.5 sodium channel blocker
0,041  0,038  Fructose-1,6-bisphosphatase inhibitor
0,053  0,050  Cyclin A inhibitor
0,140  0,138  Osteoarthritis treatment
0,064  0,063  Bulimia treatment
0,077  0,076  Estrogen-related receptor beta agonist
0,035  0,034  Vascular adhesion protein 1 inhibitor
0,104  0,103  Antimutagenic
0,070  0,070  Interferon agonist

